Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
Bulletin of Experimental Biology and Medicine|November 26, 2008
Clinical study of combined use of tomudex (raltitrexed) and xeloda (capecitabine) as first-line treatment for patients with metastasizing colorectal cancerJ V Vakhabova, N N Semenov, N V Dobrova, et al.Antibiotiki I Meditsinskaia Biotekhnologiia = Antibiotics and Medical Biotechnology|August 1, 1985
[Clinical pharmacokinetics of the antitumor antibiotic reumycin: an analysis of individual variability]A A Firsov, S V Geodakian, M R Lichinitser, et al.Biulleten' Eksperimental'Noi Biologii I Meditsiny|March 1, 1978
[Selective treatment of leukemia L1210 with combination of deoxycytidine and lethal doses of cytosine arabinoside]V M Bukhman, M R Lichinitser, G Ia Svet-Moldavskiĭ, et al.Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|July 1, 1977
Selective chemotherapy for advanced murine L 1210 leukemia by combination of 2' deoxycytidine and lethal doses of cytosine-arabinosideV M Buchman, G J Svet-Maoldavsky, M R Lichinitser, et al.Antibiotiki|September 1, 1975
[First phase in the clinical study of the antineoplastic antibiotic, carminomycin]N I Perevodchikova, V A Gorbunova, M R Lichinitser, et al.Voprosy Onkologii|August 4, 2011
[Effectiveness of DNA repair and expression of MLH1, MSH2 and FASR in lymphocytes of patients with chemotherapy-responsive, disseminated cutaneous melanoma]V A Tronov, D N Artamonov, M E Abramov, et al.Voprosy Onkologii|January 1, 1983
[Clinico-pharmacological study of prospidin]N I Perevodchikova, M R Lichinitser, A A Akyshbaev, et al.Bulletin of Experimental Biology and Medicine|November 1, 2006
Variations in the number of regulatory T cells (CD4+CD25+) in patients with breast cancer during herceptin therapyE G Slavina, A I Chertkova, T N Zabotina, et al.Eksperimental'Naia Onkologiia|January 1, 1985
[Ribamidil as a modulator of the toxic effect of 5-fluorouracil]T G Lobova, M R Lichinitser, Ia V Dobrynin, et al.Meditsinskaia Radiologiia|February 1, 1986
[Criteria for evaluating the efficacy of treatment of breast cancer metastases to the bones]M R Lichinitser, G V Vyshinskaia, A A Gritsaĭ, et al.Pageof 4